Trial Profile
Safety and efficacy of irinotecan in patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2016 New trial record